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Abstract
Background: H3K9 trimethylation (H3K9me3) and binding of PcG repressor complex-1 (PRC1) may play crucial roles in the
epigenetic silencing of the p16 gene. However, the mechanism of the initiation of this trimethylation is unknown.
Methodology/Principal Findings: In the present study, we found that upregulating the expression of PRC1 component
Cbx7 in gastric cancer cell lines MGC803 and BGC823 led to significantly suppress the expression of genes within the p16-
Arf-p15 locus. H3K9me3 formation was observed at the p16 promoter and Regulatory Domain (RD). CBX7 and SUV39H2
binding to these regions were also detectable in the CBX7-stably upregulated cells. CBX7-SUV39H2 complexes were
observed within nucleus in bimolecular fluorescence complementation assay (BiFC). Mutations of the chromodomain or
deletion of Pc-box abolished the CBX7-binding and H3K9me3 formation, and thus partially repressed the function of CBX7.
SiRNA-knockdown of Suv39h2 blocked the repressive effect of CBX7 on p16 transcription. Moreover, we found that
expression of CBX7 in gastric carcinoma tissues with p16 methylation was significantly lower than that in their
corresponding normal tissues, which showed a negative correlation with transcription of p16 in gastric mucosa.
Conclusion/Significance: These results demonstrated for the first time, to our knowledge, that CBX7 could initiate
H3K9me3 formation at the p16 promoter.
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Introduction
Epigenetic silencing is the main way for inactivation of tumor
suppressor genes such as p16 (Ink4a, CDKN2A) in numerous human
cancers [1]. Both DNA methylation and histone modifications
could suppress transcription of these genes. Epigenetic inactivation
of p16 is an intensively studied event, which plays a role in
carcinogenesis [2–4]. Unfortunately, the mechanisms of epigenetic
inactivation of such genes including p16 are still largely unknown.
Expression of p16 is regulated by a number of transcription
factors, including activator Ras, Myc, TGFb, ETS2, and silencer
pRB, Polycomb group (PcG) proteins such as EZH2, BMI1,
CBX2, CBX7, CBX8, etc [5]. Different Polycomb group
complexes regulate common target genes [6]. For instance, PcG
proteins suppress expression of Homeobox genes and the p16-Arf-p15
locus mainly through the Polycomb repressive complex-1 and -2
(PRC1 and PRC2), which control cell fate and cancer develop-
ment [6–9]. It is well known that binding of PRC2 with the p16
promoter can initiate reversible repression of its transcription
through EZH2-mediated trimethylation of histone H3 at lysine 27
(H3K27me3) [10–12]. Unlike the reversible H3K27me3, tri-
methylation of histone H3 at lysine 9 (H3K9me3) is an epigenetic
landmark of the eukaryotic genome [13–15]. Some PRC1
members such as CBX7 bind to H3K9me3 within both
heterochromatin and silenced euchromatic loci in vitro, which
might play a role in the epigenetic maintenance of transcriptional
silence of target genes [16]. SUV39H1, SUV39H2, and G9a
catalyze trimethylation of H3K9 in mammalian cells [17–19]. It is
reported that CBX7 suppresses transcription of p16 in human
fibroblast cells [20], but how CBX7 represses the transcription is
not clear. In the present study, we first report, to our knowledge,
that the PRC1 member CBX7 could initiate the formation of
H3K9me3 at the p16 promoter and thus promote the repression of
P16 expression through a SUV39H2/G9a-dependent pathway.
Results
Upregulation of CBX7 suppresses transcription of p16
through initiation of H3K9 trimethylation
To select suitable cell lines to investigate the role of CBX7 in
epigenetic inactivation of p16, we analyzed the methylation status
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lines (Figure 1 and Fig. S1). p16 Methylation was observed in 6 cell
lines including PC3 and HCT116, but not in the gastric cancer cell
lines MGC803 and BGC823. Thus, these cancer cell lines
MGC803, BGC823 (p16-active and low level of CBX7 expres-
sion), and PC3 (p16-methylated and high level of CBX7
expression) were used as the representative cell lines in the
subsequent experiments.
To set up models for silencing p16 transcription by CBX7, we
transiently transfected the wildtype Cbx7 expression vector into
MGC803 and BGC823 cells. Expression of p16 decreased in both
cell lines at 72 hours after transfection (Figure 2). Expression of Arf
and p15 located within the same locus also decreased (Figure 2B
and 2C). These results suggest that CBX7 can repress the
expression of the p16-Arf-p15 locus in these cell lines. Moreover,
weak downregulation of histone methyltransferase (HMTase) gene
G9a was observed in both cell lines 72 hours after CBX7
transfection. Although transcription of Suv39h1 was drastically
reduced in MGC803 cells, consistent downregulation was not
observed in BGC823 cells. The levels of Suv39h2 and Ezh2 mRNA
were not affected in both cell lines. Transcription of Phc2 was
downregulated, although to a weak extent (Figure 2B and 2C).
It is reported that the Pc-box within CBX7 is essential for its
binding to Ring1 and this impairs its ability to repress p16
transcription [20,21]. Mutations in critical residues of the
chromodomain (F11A and W32A, Figure S2) or deletion of the
Pc-box (DPc) inhibited the ability of CBX7 to extend the life span
of cells [20]. In the present study, we also found that the deletion
of Pc-box or chromodomain mutations only partially abolished the
repressive effect of CBX7 on transcription of p16 in the transiently
transfected cell lines. Moreover, the chromodomain mutations
abolished the downregulation of Suv39h1 in MGC803 cells
significantly. But deletion of the Pc-box had no effect on
downregulation of Suv39h1 and p15. Downregulation of Arf was
affected by the chromodomain mutation F11A (Figure 2C).
H3K9me2, H3K9me3 and H3K27me3 are well-known epige-
netic markers for gene repression. The Regulatory Domain (RD) is
reported previously to play an important role in the regulation of
p16-Arf-p15 locus [22]. To address whether histone modifications
are involved in the repression induced by CBX7, we analyzed
H3K9me3 at the p16-Arf-p15 locus and RD using chromatin
immunoprecipitation assay (ChIP). H3K9me3 was seen within the
RD and the p16 promoter and 59UTR regions in the Cbx7
transiently transfected MGC803 and BGC823 cells (Figure 3B and
3C: PS1, PS4, and PS5). Formation of H3K27me3 was not
increased within these tested loci (Figure 3C). H3K9me2 was not
detectable either (data not shown). Binding of CBX7 mutant
proteins to five tested DNA fragments within the p16-Arf-p15 locus
Figure 1. CBX7 expression and transcription of Cbx7 and p16 in human cancer cell lines. (A), analysis of CBX7 expression by Western blot.
(B) analysis of of Cbx7 (up) and p16 (down) expression by quantitative RT-PCR. The methylation status of p16 CpG island is marked according to the
results displayed on Figure S1.
doi:10.1371/journal.pone.0013732.g001
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PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13732Figure 2. Effects of CBX7 on expression of the p16-Arf-p15 locus, HMTases, and genes at other loci. Results of two independent
experiments were displayed. (A), analysis of expression of Cbx7 in MGC803 cells 72 hours after transfection by Western blot assays. (B), analysis of
transcription level of genes located within the p16-Arf-p15 locus, two control genes (Ezh2 and Phc2) located at other loci and three HMTases, in
BGC823 cells 72 hours after transfection by quantitative RT-PCR. (C), analysis of transcription level of genes located within the p16-Arf-p15 locus, two
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either (Figure 3D).
In the CBX7-stably transfected MGC803 subclone(s), in which
downregulation of p16 expression is maintained, expression of
Suv39h1and Suv39h2 increased significantly (Clone-1 and Clone-2;
Figure 4A and 4B). The H3K9me3 formation was shown within the
tested p16 promoter (Figure 4C: PS4), though p16 methylation was
not observed in these subclones even at passage 80 by methylation-
specific PCR (MSP) (Figure 4D: Clone-1 and Clone-2).
In addition, transient knockdown of CBX7 by siRNA did not
reactivate P16 expression in p16-methylated PC3 cells (Figure 5A).
Stably knockdown of CBX7 by shRNA inhibited the growth of
PC3 cells (Figure 5B), but induced neither p16 transcription
(Figure 5C) nor demethylation of p16 CpG island (Figure 5D).
Significant change of H3K9me3 level at the five tested fragments
was not observed (Figure 5E). However, significant upregulation of
the transcription of Arf and p15 was observed in PC3 cells
(Figure 5C).
SUV39H2 and G9a contribute to H3K9 trimethylation
within the p16 59UTR induced by CBX7
G9a, SUV39H1 and SUV39H2 are three histone methyltrans-
ferases (HMTases) involved in trimethylation of H3K9. Hence, we
studied which HMTase was the enzyme responsible for the
trimethylation of H3K9 after CBX7 upregulation. We initially
analyzed the binding of SUV39H2 with p16-Arf-p15 locus by ChIP
assay, and found that SUV39H2 was weakly recruited to the p16
59UTR in cell lines transiently transfected with CBX7 (Figure 3B
and 3C), but strongly in the tested CBX7-stably upregulated
subclone-2 (Figure 4C). Thus, bimolecular fluorescence comple-
mentation assay (BiFC) was further used to detect the possible
interaction between CBX7 and SUV39H2. Amino acids 173–238
of YFP (YC) were fused to the C-termini of SUV39H2 to construct
the YC-Suv39h2 vector. The VN-Cbx7 vector, containing the N-
terminal 172 amino acids of Venus (VN) fused to the N-termini of
CBX7 protein, was also used in the BiFC assay, because it remains
an active CD domain with high affinity to Histone 3.2 and 3.1
[23]. Images of the BiFC complex of CBX7-SUV39H2 (yellow)
and Hoechst (blue) fluorescence were obtained in BGC823
(Figure 6) and MGC803 cells 36 hours upon transfection (Figure
S3). Interaction between CBX7 and SUV39H2 was mainly
observed within the nucleus, especially the Hoechst-negative
staining areas in both cell lines (Figure 6 and Figure S3). Such
interaction could not be observed in the tested cells transfected
with blank VN- and YC-vector controls. Interaction between
CBX7 and Histone 3.1 positive control was mainly observed
within the Hoechst-positive staining area (Figure 6). At the same
time, we cloned Cbx7 into the pEFGP-C1 vector and transfected it
to MGC803 cells and found that CBX7 was distributed in the
entire nucleus with higher concentration at the Hoechst-negative
staining areas (Figure S3), which was consistent with the BiFC
results. Although CBX7-Histone 3.1 complexes were observed in
Co-IP assay, CBX7-SUV39H2 complexes were not detected
(Figure S4).
Moreover, a rescue assay was carried out to evaluate the role of
SUV39H2 in the formation of H3K9me3 within the p16 promoter
induced by CBX7. We found that knockdown of Suv39h2
expression by siRNA abolished the formation of H3K9me3, and
therefore rescued p16 expression in the tested subclone (CBX7
Clone-2; Figure 7A,C). Moreover, decrease of H3K9me3 was
also observed after knockdown of G9a by siRNA, but it could not
be detected in the tested cells after treatment with siRNA-
Suv39h1, although p16 expression was increased after these
siRNA treatments (Figure S5). These results together indicate that
CBX7 may repress p16 expression by recruiting SUV39H2 to the
p16 59UTR to induce the formation of H3K9me3. In addition, in
the p16-methylated PC3 cells, after stably knockdown of CBX7,
p16 transcription was still not detectable upon further knockdown
of Suv39h2 and/or Suv39h1 expression by siRNAs. Again,
knockdown of Suv39h1 led to upregulation of Suv39h2, whereas
knockdown of Suv39h2 did not lead to upregulation of Suv39h1 in
the PC3 cells (Figure S6).
Expression alterations of CBX7 and other PRC1
components in human gastric carcinomas
To validate whether epigenetic silence of p16 expression
correlates negatively with transcription of Cbx7 and its related
components in vivo, we first analyzed p16 methylation status
quantitatively by DHPLC and MethyLight in human primary
gastric carcinoma samples (GC), the corresponding cutting-edge
normal tissues of GC (GCN), and human normal gastric mucosa
biopsies from non-cancer patients (Normal). Peak for methylated-
p16 (p16M) was observed in eleven gastric carcinoma samples:
F0110 (14%), F0160 (24%), F0198 (30%), F0212 (10%), F0240
(38%), F0500 (9%), F0650 (13%), F0856 (14%), F0918 (38%),
F1070 (16%), and F1176 (19%) (Figure 8). The results were
confirmed by MethyLight (Figure 8, inserted chart) and bisulfite
clone sequencing (data not shown).
We also analyzed the transcription levels of p16, Cbx7, and other
6 PcG genes in these samples by quantitative RT-PCR (Table 1).
Expression of p16 in GCs with p16 methylation was lower than
that without p16 methylation, but not significant (Table 1,
P=0.067; the lower DCt value, the higher mRNA amount).
Transcription of Cbx7 in GCs was lower than that in GCNs,
especially in GCs with p16 methylation (P=0.009). Transcription
of p16 in GCNs (and GCs) was significantly higher than in Normal
samples (P=0.003) whereas transcription of Cbx7 in GCNs (and
GCs) was significantly lower than in Normal samples (P=0.039),
which suggest an inverse relationship between transcription of p16
and Cbx7 among gastric samples without p16 methylation.
Interestingly, in Normal tissues from 18 non-cancer patients, we
found that transcription of Cbx7 was positively correlated with those
ofRing1,Bmi1, Mel18,an dPhc2,butnot with thoseofCbx8 and Ezh2
(Figure 9, left chart; Ps,0.01). However, in GCN and GC samples
from 20 cancer patients, such correlation was progressively
disturbed, especially between Cbx7 and Ring1/Mel18 (Figure 9,
middle and right chart). Moreover, in contrast to Cbx7 expression,
the average expression levels of Ezh2 in Normal, GCs and GCNs
were similar in the samples without p16 methylation, but
transcription of Ezh2 in GCs with p16 methylation was significantly
higher than that in GCNs (P,0.000). These results suggest that
expression patterns of PcGs, especially CBX7, are changed during
development of gastric carcinoma and may affect p16 expression in
the human stomach in vivo.
control genes (Ezh2 and Phc2) located at other loci and three HMTases, in MGC803 cells 72 hours after transfection by quantitative RT-PCR. P-value
less than 0.05 for CBX7/mutants vs. CTRL was listed below each column, respectively. Each column represents the average value of triplicate. The
STDEV value was on the top of column. CTRL, cells transfected with the pcDNA3.1(+)/myc-His A control vector; CBX7, cells transfected with the vector
containing the full coding region of wildtype Cbx7. DPc, Pc-box deleted CBX7; F11A and W32A, CBX7 containing F11A and W32A mutation within
chromodomain, respectively.
doi:10.1371/journal.pone.0013732.g002
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PLoS ONE | www.plosone.org 4 October 2010 | Volume 5 | Issue 10 | e13732Figure 3. H3K9me3 formation, CBX7 and SUV39H2 binding within p16 and Regulatory Domain regions in ChIP assays. (A), locations
of the p15-Arf-p16 locus at chromosome 9 and the corresponding fragments amplified with primers (PS1,5) used in ChIP assays (based on web
http://genome.ucsc.edu, Mar. 2006, assembly). (B) and (C), analysis of H3K9me3 formation by ChIP assay in cell line MGC803 and BGC823 transiently
transfected with Cbx7 expression vector, respectively. H3K9me3 formation, CBX7- and SUV39H2-binding were also analyzed by quantitative ChIP
assays in these cell lines. (D), results of CBX7-binding and H3K9me3 formation by ChIP assays in BGC823 cells 72 hours after transfected with the
wildtype and mutant Cbx7-vectors. *, versus the wildtype CBX7, P,0.05; Ctrl, cells transfected with the control vector pcDNA3.1(+)/myc-His A; Cbx7,
cells treated with the vector encoding full length of coding region of the wildtype CBX7; DPc, Pc-box deleted CBX7; F11A and W32A, CBX7 containing
F11A and W32A mutation within chromodomain, respectively; % of Input, the percentage of the average relative copy number of the tested
triplicates to that of Input control.
doi:10.1371/journal.pone.0013732.g003
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Epigenetic inactivation of p16 is a well-studied event during
carcinogenesis. The detailed mechanism of p16 inactivation by
DNA methylation and histone modification is still unclear. It is
well known that H3K9me3 and PRC1 formation in the silenced
euchromatic loci, such as the methylated p16-Arf locus, are
epigenetic inactivation landmarks (Figure 10). Heterochromatin
binding protein HP1 can bind with H3K9me3 [13]. Interactions
between the PRC1 member CBX7 and H3K9me3 are also
observed in in vitro peptide pull-down assays [16]. However, it is
largely unclear how the locus specific H3K9 trimethylation is
initiated during its epigenetic silence processes. In the present
study, we first observed, to our knowledge, that the possible
H3K9me3 binding protein CBX7 itself could initiate the specific
formation of H3K9me3 via HMTase SUV39H2-dependent
pathways in the p16 locus within gastric cancer cell lines.
It is reported that CBX7 promotes proliferation of several
human cell lines by repression of p16 expression [6,20,21]. To
understand the possible mechanisms through which CBX7
represses p16 transcription, we established CBX7 overexpression
models by transfecting wildtype CBX7 expression vector to
MGC803 and BGC823 cells and found both transiently and
stably upregulated CBX7 could repress p16 expression in these
gastric cancer cell lines, increase levels of H3K9me3 within the
p16 promoter and RD regions. But an increase of H3K27me3 and
H3K9me2 was not detectable within the same regions. CBX7
binding to these regions suggests that CBX7 may repress p16
expression through initiating or protecting trimethylation of
H3K9. Although consistent recruitment of SUV39H2 to the p16
promoter and 59UTR regions is not observed in two CBX7
transiently upregulated cell lines, it is found that SUV39H2 is not
only upregulated, but also recruited to the p16 59UTR in the
CBX7 stably transfected subclones. This indicates that SUV39H2
may be involved in the maintenance of the established H3K9me3
pattern. Like CBX7-GFP, main interaction between CBX7 and
SUV39H2 was observed in the Hoechst negative staining area in
BiFC assay. Weak interactions of CBX7 with SUV39H2 were also
observable in the Hoechst positive staining area. Both are
consistent with the distribution of CBX7. These results indicate
that CBX7 and SUV39H2 may function together physically
within chromatin in the transfected cells. CBX7 could interact
with Histone 3.2 or 3.1 directly in BiFC assay [23]. Such
interaction between CBX7 and H3.1 in nucleus was also observed
in the BiFC assay. Moreover, we found the complex of Myc-
CBX7 and YC-H3.1 in Co-IP assay. Unfortunately, we did not
find the complex of Myc-CBX7 and YC-SUV39H2 in the Co-IP
assay. The lower detection sensitivity of Co-IP compared to that of
the BiFC assay and weak interaction between CBX7 and
SUV39H2 might account for the result difference. Taken together,
it is reasonable to make the assumption that SUV39H2 may
responsible for the formation of H3K9me3 at the p16 promoter. It
supports our hypothesis that knockdown of SUV39H2 inhibited
the formation of H3K9me3 and rescued p16 expression. Another
HMTase G9a, but not SUV39H1, might also contribute to the
H3K9 trimethylation. We conclude that CBX7 could initiate or
maintain H3K9 trimethylation at the p16 locus in a SUV39H2/
G9a-dependent pattern. Although we did not observe CBX7-
induced H3K9me3 formation within the p15 and Arf promoter, we
cannot exclude that CBX7 induces trimethylation of other genes
in the SUV39H2-dependent way.
CBX7 protein contains a C-terminal Pc-box and a N-terminal
chromodomain. The binding of the Pc-box to Ring1 is necessary
for the repression of p16 expression. The chromodomain plays an
Figure 4. HMTase expression, H3K9me3 formation, SUV39H2 binding, DNA methylation within p16 CpG island. (A), analysis of
expression of Suv39h1 and Suv39h2, p16, and Cbx7 in two CBX7-stably transfected MGC803 subclones by quantitative RT-PCR. (B), analysis of CBX7
and P16 expression in the CBX7-stably transfected subclones by Western blot. (C), ChIP analysis of H3K9me3 formation within the p16 promoter and
recruitment of SUV39H2 to the 59UTR of p16 gene in Clone-2. The target PCR product is marked by an arrow. (D), analysis of p16 methylation by
methylation-specific PCR (MSP). Genomic DNA of AGS cell line was used as positive control (p.c.) for p16 methylation in the MSP assay. CTRL: MGC803
cell stably transfected with pcDNA3.1(+)/myc-His A control vector; Clone-1/-2: the two MGC803 subclones stably transfected with vector containing
the full coding region of wildtype Cbx7; Exp-1/-2: two independent experiments.
doi:10.1371/journal.pone.0013732.g004
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heterochromatin and silenced euchromatic loci [16,20,21].
Mutations in critical residues of chromodomain (F11A and
W32A) or deletion of the Pc box (DPc) inhibited the ability of
CBX7 to extend the life span [20]. In the present study, we found
that all of these mutants only partially abrogated the repressive
function of CBX7 on p16 expression, because the residual function
of these mutants was still significant. Most importantly, we found
that CD mutations or deletion of the Pc-box of CBX7 abolished
binding of CBX7 to the tested DNA fragments and greatly
disrupted the induction of H3K9me3 within the p15-Arf-p16 locus
in ChIP assays. These results demonstrate that both functional
motifs within CBX7 protein contribute to the repression of the
p15-Arf-p16 locus through the H3K9me3 formation.
Mouse CBX7 displays strong affinity for both H3K9me3 and
H3K27me3 in vitro and is developmentally regulated in its
association with chromatin [16,23]. In the present study, we did
not find an increase of H3K27me3 formation within the p16
promoter. The HMTase EZH2 is responsible for H3K27
trimethylation. Upregulation of Ezh2 was not observed in the
Cbx7 upregulated cells either. Whether CBX7 binding to
H3K27me3 is a prerequisite for recruitment and/or activation
of SUV39H2 to the p16 promoter and subsequent trimethylation
of H3K9 is unclear.
Recently, it is reported that enforced upregulation of CBX7
promotes E-cadherin expression in 293T cells through its physical
interaction with HDAC2 and inhibited its activity within the E-
cadherin promoter [24]. In contrast, CBX7 could bind to DNMT1
and induce methylation of E-cadherin and other tumor suppressor
genes, not including p16, in the embryonal carcinoma cell line
Tera-2 [25]. G9a-DNMT complexes were also detected in
colorectal cancer cell line RKO [25]. In the present study, we
did not analyze changes of epigenetic modifications within the E-
cadherin promoter because E-cadherin is methylated in both
MGC803 and BGC823 cell lines [26]. We analyzed the p16
promoter and did not find methylation of CpG islands of p16 in
Figure 5. Effect of downregulation of Cbx7 on expression of p16/Arf/p15, cell growth and p16 methylation. (A), analysis of CBX7
expression in PC3 cells by Western blot assay 72 hours after CBX7 knockdown. Protein extracted from 293T cells was used as P16 positive control
(P16-p.c.). (B), the growth curves of PC3 cells stably transfected with the scramble control shRNA vector (shR-Ctrl) or shRNA-Cbx7 vector (shR-Cbx7) in
MTT assay. (C), analysis of transcription of Cbx7, Arf, and p15 by quantitative RT-PCR. The statistical significance of the differences of mRNA relative
copy number between cells stably transfected with shR-Ctrl and shR-Cbx7 were labeled above the top of one of the columns. (D), analysis of p16
methylation by MSP in the Cbx7 stably knockdown PC3 cells. Genomic DNA from AGS and MGC803 cell lines was used as positive control of
methylated and unmethylated p16 respectively. (E), comparison of H3K9me3 level by ChIP assays within various locations as illustrated in Figure 3A.
doi:10.1371/journal.pone.0013732.g005
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H3K9me3 formation was detected in the p16 59 UTR, which may
account for the downregulation of p16 transcription. This
difference may be due to the different cell lines used in each
study. It also implies that CBX7 have multiple functions and thus
regulate gene expression through different mechanisms. Addition-
ally, we also found that stable knockdown of CBX7 by shRNA did
not induce de-repression of p16 expression and demethylation of
p16 CpG island in PC3 cell line either even after Suv39h2 and/or
Suv39h1 were knockdown by siRNAs. Similar results in RKO cell
line were also reported [25]. In consideration of above observation
that CBX7 is downregulated in primary gastric carcinomas with
p16 methylation and CBX7 knockdown does not induce
demethylation of p16 in PC3 cells, it is likely that CBX7
upregulation may be sufficient for induction or maintenance of
H3K9me3, but not for the establishment of DNA methylation
within the p16 locus. Because of the close relationship between
H3K9me3 and initiation of DNA methylation, additional studies
will reveal whether CBX7 upregulation is necessary for initiation
of DNA methylation of p16.
We found that upregulation of CBX7 decreased transcription of
Arf and p15, while downregulation of CBX7 increased transcrip-
tion of Arf and p15, which is the same as p16 gene. Unlike within
p16, H3K9me3 formation within the Arf and p15 loci was not
observed in the tested cancer cell lines after transiently transfection
of CBX7. Correlation between Cbx7 expression and Arf methyl-
ation/transcription was not observed in the present study either
(data not shown). These phenomena imply that CBX7 may favor
to repress p16 more than it does Arf and p15. It is reported that RD
regulates expression of the p15-Arf-p16 locus simultaneously [5,22]
and we observed H3K9me3 formation at RD region after CBX7
transfection. Thus, formation of H3K9me3 within the RD might
Figure 6. Distribution of CBX7-SUV39H2 complexes in cancer cell line BGC823 in bimolecular florescence complementation (BiFC)
assay. 36 hours after transfection, images of the BiFC complex of CBX7-SUV39H2 (yellow) and Hoechst (blue) fluorescence were obtained and
merged. The blank VN- and YC-vectors were used as negative controls. VN-CBX7 and YC-Histone 3.1 (H3.1) vectors were used as positive controls.
doi:10.1371/journal.pone.0013732.g006
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induced by CBX7.
Polycomb proteins such as EZH2, BMI1, CBX8, and CBX7
may play important roles in suppressing the expression of the p16-
Arf locus in vitro [6,7,12,27,28]. However, which kind of PcG
protein may contribute to epigenetic silence of this locus in vivo is
not evaluated yet. Others have reported downregulation of Cbx7 in
human cancer tissues previously [28–31]. The relationship
between transcription of Cbx7 and p16 is not evaluated in gastric
tissues. To validate the repression effect of CBX7 on transcription
of p16 in vivo, the relationships between transcription of p16, Cbx7
and other PRC1 components were analyzed using Normal gastric
mucosa biopsies from 18 non-cancer patients and paired GCs and
GCNs from 20 cancer patients (Table 1). We found that
transcription of Cbx7 was significantly lower in GCs than in
GCNs, especially among samples from patients with GCs
containing p16 methylation. Furthermore, we observed that Cbx7
expression was negatively correlated with p16 expression:
transcription level of Cbx7 was high in Normal tissues with low
level of p16 transcription, but it was low in GCNs and GCs with
high level of p16 transcription. This provides in vivo evidence that
CBX7 may be involved in the repression of p16.
In addition, we also found for the first time that transcription of
Cbx7 was significantly correlated with those of other PRC1
components Bmi1, Mel18, Ring1, and Phc2 in Normal gastric tissues,
while not with those of Cbx8 and Ezh2. However, such correlations
were progressively disturbed in GCNs and GCs.
Downregulation of Cbx7 in GCs and GCNs may account for
disruption of these correlations. It was reported that MEL18 could
repress BMI1 in cancer cells [32] and knockdown one of PcGs
might release other PcGs from its target gene (such as p16) [7]. We
proposed that the correlated expression pattern of these PcGs in
normal gastric tissues might be necessary for maintenance of their
normal functions, and disruption of the pattern might result in
abnormal repression of their target genes.
In conclusion, we found that the PRC1 member CBX7 could
initiate trimethylation of H3K9 at the p16-Arf locus through
recruitment and/or activation of the HMTase SUV39H2 to the
target locus. This finding links two repressive epigenetic landmarks
H3K9me3 formation and PRC1 binding within the silenced
domains in euchromatin together, and builds up a full pathway
for epigenetic inactivation of p16 by histone modifications
(Figure 10).
Materials and Methods
Cell lines and human gastric samples
Human cell lines BGC823, HepG2, MGC803, RKO, and
SGC7901 were cultured in RPMI1640 medium with 10% FBS.
Human cell line Caski, Colo205, HCT116, HeLa, MHCC97H,
Siha, and SW480 were cultured in DMEM medium with 10%
FBS. AGS and PC3 were cultured in F12 medium with 10% FBS.
All of these cell lines were cultured at 37uC with 5% CO2. PC3 cell
line was purchased from Cell Line Bank, Chinese Academy of
Medical Science. RKO cell line was kindly provided by Dr.
Guoren Deng at University of California San Francisco. SW480
and HCT116 cell lines, by Dr. Yuanjia Chen at Peking Union
Hospital. HepG2 (from Qingyun Zhang), MGC803, BGC823,
SGC7901, HeLa, Caski, Siha, and other cell lines (from Dr. Yang
Ke) were obtained from laboratories at Beijing Cancer Hospital/
Figure 7. Effect of siR-Suv39h2 on p16 expression, H3K9me3, and binding of SUV39H2 within the p16 59UTR. The CBX7-stably
transfected MGC803 subclone CBX7 Clone-2 was analyzed 72 hours after knockdown of Suv39h2 by siRNA. (A), analysis of P16 expression by Western
blot. (B), analysis of transcription of Suv39h2 by quantitative RT-PCR. (C), analysis of H3K9 trimethylation (K9me3) within the p16 promoter by ChIP
assays. siR_Ctrl, scramble siRNA control; siR_Suv39h2, siRNA targeted to Suv39h2.
doi:10.1371/journal.pone.0013732.g007
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cells were harvested for extraction of proteins, mRNA, and DNA
samples as described below. Proliferation of cells was analyzed
with MTT assay.
Twenty paired primary gastric carcinoma (GC) and their
corresponding cutting-edge normal tissue (GCN) samples from
GC patients (11 males and 9 females, 33–74 years old, the average
age 59-y) and 18 gastric normal biopsies (Normal) from non-cancer
patients (with or without mild/moderate chronic gastritis)
were collected and fresh-frozen at 270uC at Beijing Cancer
Hospital. All clinical samples and histopathological information for
each case were obtained according to approved institutional
guidelines.
Ethics Statement
Informed consent was obtained from all subjects and the
institutional review committee approved this study.
Plasmid construction and transfection
Coding region of CBX7 (GenBank accession no. XM_066324)
was cloned into pcDNA3.1(+)/myc-His A vector (Invitrogen) to
get the wildtype CBX7 expression vector. To construct mutant
vectors, point mutations of caging aromatic residues (F11A and
W32A; Figure S2) within the chromodomain of CBX7 and the Pc-
box (231–242 amino acids)-deleted CBX7 (DPc) were created
using Easy Mutagenesis System (FM101; Transgene). These
plasmids were transfected to MGC803 and BGC823 cells using
Lipofectamine
TM 2000 (11668-027; Invitrogen) according to the
manufacturer’s instruction, respectively.
ShRNAagainstCbx7 was constructed by oligonuleotide targeted to
Cbx7 mRNA (110 nt–128 nt: 59-caaag tacag cacgt ggga-39) (accession
number XM_066324) in pGFPU6/Neo shRNA expression vector
including GFP coding sequence (GenePharma Company, Shanghai).
The scramble shRNA (59-gttct ccgaa cgtgt cacgt-39)w a su s e da s
negative control. These plasmids were transfected to PC3 cells.
Generation of the stable cell clones
Wildtype CBX7 expression vector and the control vector were
transfected to MGC803 cells. After transfection, cells were
cultured in selective medium containing G418 (700 mg/ml). Two
subclones (Clone-1 and Clone-2) stably expressing CBX7 and one
control cell clone were obtained.
PC3 cells with stable knockdown of Cbx7 were obtained by
sorting twice with FACS as followed. 24 hours after transfection,
PC3 cells were cultured in the selective medium containing
300 mg/ml of G418 for 3 weeks. Then, these cells were sorted by
FACS. GFP-positive cells were collected and cultured in the
selective medium, and sorted again after 3 weeks’ culture.
Protein preparation and Western blot analysis
Total protein was extracted from cultured cells or fresh tissue
samples with TRIzol reagent (Invitrogen) according to the
manufacturer’s instruction. Immunoblotting was performed with
the following antibodies: rabbit anti-CBX7 (Ab21873; Abcam),
mouse anti-P16 (Ab50282; Abcam), and mouse anti-b-ACTIN
(Santa Cruz). Chemiluminescent reagent (Pierce, Thermal) was
used to display the protein bands transferred on the PVDF
membrane (Millipore).
Figure 8. DHPLC chromatogram of methylation status of p16 CpG island in human primary gastric carcinoma. 20 pairs of gastric
carcinomas (with even ID) and their corresponding normal samples (with odd ID) were analyzed by DHPLC. The inserted chart displayed that the
result of DHPLC detection correlated with that of quantitative MethyLight analysis well (R
2=0.745; P=0.000).
doi:10.1371/journal.pone.0013732.g008
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PLoS ONE | www.plosone.org 10 October 2010 | Volume 5 | Issue 10 | e13732Table 1. Comparison of transcription levels (DCt in qRT-PCR assay, a high DCt value means low transcription) of p16 and seven
PcG genes in different kinds of human gastric mucosa samples with and without p16 methylation.
PcGs p16M
a DCt in qRT-PCR (Mean±SD) P-value, vs. GCN
GC (n=20)
b/c GCN (n=20) Normal (n=18) GC
d Normal
p16 Positive 12.6262.59
b/e 11.3461.39
f 0.217
Negative 10.4262.41
c 11.8062.03 14.6361.48
g 0.243 0.003
(Total) 11.6362.41 11.5562.03 0.919
Cbx7 Positive 8.9461.08 7.4261.37 0.009
Negative 7.7762.23 6.9461.42 5.5461.77 0.364 0.039
(Total) 8.4161.75 7.261.37 0.019
Ring1 Positive 6.8160.82 7.2961.65 0.359
Negative 6.6761.34 6.5761.37 6.6261.38 0.886 0.927
(Total) 6.7461.06 6.9761.53 0.595
Bmi1 Positive 9.2160.86 9.5661.29 0.459
Negative 8.2361.66 8.5860.80 8.4662.24 0.584 0.764
(Total) 8.7761.34 9.1261.18 0.389
Mel18 Positive 4.8160.88 5.8261.35 0.051
Negative 4.8661.10 4.9761.46 5.8061.63 0.871 0.198
(Total) 4.8360.96 5.4461.43 0.128
Phc2 Positive 9.2160.90 9.2561.33 0.994
Negative 8.2561.77 8.2661.16 9.3362.3 0.991 0.213
(Total) 8.7861.42 8.861.32 0.959
Cbx8 Positive 9.1760.68 9.3860.47 0.420
Negative 8.5060.93 9.0960.72 8.0461.34 0.149 0.014
(Total) 8.8760.85 9.2560.6 0.110
Ezh2 Positive 5.3861.19 8.9061.53 0.000
Negative 6.5361.73 6.7261.66 6.6162.27 0.816 0.885
(Total) 5.9061.53 7.9261.90 0.001
GC: human primary gastric carcinoma sample; GCN: the corresponding cutting- edge tissues of GC; Normal: human normal gastric mucosa biopsies from non-cancer
patients;
amethylation of p16 CpG island (p16M) in gastric mucosa tissues from patients with or without cancer;
bGC samples from 11 patients are p16M-positive;
cGC samples from 9 patients are p16M-negative;
dpaired t-test;
ep16M-positive GCs vs. p16M-negative GCs, P=0.067;
fp16M was detectable in GCs, but not in the corresponding GCN by DHPLC;
gp16 mRNA was detectable in 12 of 18 Normal gastric biopsies; all of 18 Normal samples are p16M-negative.
doi:10.1371/journal.pone.0013732.t001
Figure 9. Correlation coefficients between mRNA levels of PcG genes in various kinds of gastric mucosa samples. The relative copy
numbers (RCN) was calculated based on the average Ct number of target gene and the GAPDH reference [2
-(Cttarget_gene-CtGAPDH)]. The correlation
coefficients was calculated based on each gene’s RCN for each sample within different groups, including normal gastric mucosa biopsies (Normal,
N=18), gastric carcinomas (GC, N=20) and their corresponding normal samples (GCN). The significance of correlation coefficients was calculated
using the statistic software SPSS16.0 and marked with */** (P,0.05/0.01).
doi:10.1371/journal.pone.0013732.g009
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PCR) assays
Total RNA was isolated using RNeasy mini kit (Cat. #74104,
QIAGEN) according to the manufacture’s instruction. Total
RNA was reverse transcripted into cDNA using ImProm-II TM
Reverse Transcription System (A3800; Promega). Quantitative
RT-PCR was performed using power SYBR Green PCR
Master Mix (P/N 4367659, Applied Biosystems) on an ABI-
7500 Real-Time PCR system (Applied Biosystems). Cbx7
mRNA level was quantified with TaqMan kit (Roche). The
primer sets for the tested genes were listed in Table 2. The
relative gene mRNA level was calculated based on the average
Ct number of target gene and the GAPDH reference
[2
-(Cttarget_gene-CtGAPDH)]. SPSS16.0 software was used to analyze
the data.
DNA preparation, bisulfite treatment, and DNA
methylation analysis
Genomic DNA of cell lines and tissue samples was isolated with
phenol/chloroform extraction and modified with 5.0 M sodium
bisulfite [33]. p16 methylation was analyzed with MSP, DHPLC,
MethyLight, and clone sequencing [34]. Because of PCR bias
favoring amplification of the unmethylated templates, the ratio
(0.285) of the peak area for the methylated p16 to that for the
unmethylated p16 in the p16-hemimethylated HCT116 cell was
used as the constant to adjust the observed ratios for the tissue
samples. Primer sets used were listed in Table 2.
RNA interference assay
The knockdown of Suv39h2 (sc-106822; Santa Cruz) and
Suv39h1 (sc-38463; Santa Cruz) and G9a (sc-43777; Santa Cruz)
Figure 10. Epigenetic silencing pathway for the p16-Arf-p15 locus. Gene repression pressure leads to recruitment of EZH2-containing
Polycomb repressive complex-2 (PRC2) to the transcription complex, that trimethylates H3K27 and thus initiates the repression. The PRC2-related
repression is reversible under condition of transcription pressure. However, in the case of long-term silence, Polycomb repressive complex-1 (PRC1) is
recruited to the PRC2-repressed genes and activates H3K9 trimethylation subsequently, which may subsequently induce DNA methylation and
chromatin remodeling with assistance of other silencers including DNMTs, HDACs, and heterochromatin binding protein HP1. The content within the
yellow dash-square presents the discovery in the present study that connects two epigenetic landmarks the PRC1 binding and H3K9 trimethylation
together.
doi:10.1371/journal.pone.0013732.g010
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Gene name Entrez Gene Assay Oligo name Primer Sequence (59R39)
PCR
Products Tm (uC) References
Cbx7 23492 RT-PCR Cbx7-F aaagtcgagtatctggtgaagtgg 442bp 66
Cbx7-R gctcccgtcgatggctgtgg
qRT-PCR Cbx7-qF cgtcatggcctacgagga 71bp 54 Pallante et al, 2008
Cbx7-qR tgggtttcggacctctctt
Cbx7-qProbe aggaggag
Cbx8 57332 qRT-PCR Cbx8-qF ctcgtgaaatggaagggatggt 222bp 53
Cbx8-qR gatgcccctggctgagtcact
Bmi-1 648 qRT-PCR Bmi1-qF aattagttccagggcttttcaa 120bp 60
Bmi1-qR cttcatctgcaacctctcctctat
Ezh2 2146 qRT-PCR Ezh2-qF cggggatagagaatgtgggttta 173bp 60
Ezh2-qR aggtgggcggctttctttatcatc
Mel18 7703 RT-PCR Mel18-qF tggggatggggacaaagagaaaac 200bp 60
Mel18-qR tccgccgccaggggtagat
Suv39h1 6839 qRT-PCR Suv39h1-qF ggcaacatctcccactttgt 250bp 56
Suv39h1-qR caatacggacccgcttctta
Suv39h2 79723 qRT-PCR Suv39h2-qF cccatctatgaatgcaactcaag 313bp 56
Suv39h2-qR caaaatgagacacattgccgtat
G9a 10919 qRT-PCR G9a-qF ctaccgaacagccaagatg 297bp 61
G9a-qR aactgaagaaggcgatgc
Phc2 1912 qRT-PCR Phc2-qF aatcctgacgcatgttatcg 275bp 62
Phc2-qR gcttggaacgcttgaacttat
Ring1 6015 qRT-PCR Ring1-qF tgggaactgagtctgtatgagc 229bp 56
Ring1-qR tctttcggcaggtaggaca
RD ChIP-PS1 RD-cF ccacttatgcagttcctcacc 216bp 56 NT008413.18
RD-cR gtcattaaacaggctgaacc
p15 1030 qRT-PCR p15-qF agtcaaccgtttcgggaggcg 168bp 62
p15-qR accaccagcgtgtccaggaag
ChIP-PS2 p15-cF ggaacctagatcgccgatgtag 74bp 56
p15-cR tgttttacgcgtggaatgcac
p14-Arf 1029 qRT-PCR p14-qF gccaggggcgcccgccgctg 236bp 62
p14-qR ggcccggtgcagcaccacca
ChIP-PS3 p14-cF gtgggtcccagtctgcagtta 61bp 56
p14-cR cctttggcaccagaggtgag
p16 1029 (q)RT-PCR p16-F gctgcccaacgcaccgaata 180bp 62
p16-R accaccagcgtgtccaggaa
ChIP-PS4 p16-1cF cggctgggagcagggaggc 155bp 62 Bracken et al, 2007
p16-1cR gaatgtggcacccctgaagtcgc
ChIP-PS5 p16-2cF gtccccttgcctggaaagata 154bp 62 Bracken et al, 2007
p16-2cR tctccgcagccgccgag
MSP-U p16U-F ttattagagggtggggtggattgt 234bp 62 Herman et al, 1996
p16U-R ccacctaaatcaacctccaacca
MSP-M p16M-F ttattagagggtggggcggatcgc 234bp 62 Herman et al, 1996
p16M-R ccacctaaatcgacctccgaccg
DHPLC p16-uniF tttttagaggatttgagggatagg 392bp 70R60 Luo et al, 2006
p16-uniR ctacctaattccaattcccctacaaacttc
Col2A1 Col2A1-qF tctaacaattataaactccaaccaccaa 92bp 60 Widschwendter et al,
2004
Col2A1-qR gggaagatgggatagaagggaatat
Col2A1-qProbe ccttcattctaacccaatacctatcccacctctaaa
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siRNA (59-uucuc cgaac guguc acgu-39) was used as the negative
control. Expression level of target gene was analyzed with qRT-
PCR and/or Western Blot assays 72 hours after transfection.
Chromatin Immunoprecipitation Assay (ChIP)
ChIP assays were performed and analyzed essentially as
described [35]. The antibodies used were rabbit anti-H3K9me3
(07-625; Upstate), rabbit anti-H3K9me2 (07-441; Upstate), rabbit
anit-H3K27me3 (07-449; Upstate), goat anti-SUV39H2 (Ab5264;
Abcam), rabbit anti-Myc (Ab9132; Abcam). Rabbit anti-Myc
antibody was used to precipitate exogenous CBX7 protein. The
enrichment of specific genomic regions was assessed relative to the
control IgG (ZB-2301, Zhongshan). Each ChIP experiment was in
triplicates and repeated at least three times. Primer sets used were
listed in Table 2.
Confocal Fluorescence Microscopy and BiFC assay
To produce fusion proteins for BiFC analysis, the N-terminal
172 amino acids of Venus (VN) was fused to the N-termini of
human CBX7 protein (kindly provided by Claudius Vincenz) [23].
Amino acids 173–238 of YFP (YC, provided by Claudius Vincenz)
were fused to the C-termini of SUV39H2. The sequences
encoding all fusion proteins were verified and are available upon
request. BiFC complexes and co-localization of different PcG
proteins in transiently expressing cells were imaged 36 hours after
transfection. Cells grown on cover glass were stained with 10 ng/
ml Hoechst33342 (Sigma) for 30 min, and fixed in 2%
formaldehyde for 10 min at room temperature, washed with
phosphate-buffered saline, and mounted for microscopy. The
fluorescence images were acquired by using a Leica inverted
fluorescence microscope under oil objective. Blank VN- and YC-
vector controls were used as negative controls. YC-Histone 3.1
(H3.1, kindly provided by Claudius Vincenz) was used as positive
control.
Co-IP assay
After HEK293 were transfected with the YC-SUV39H2 (or -
H3.1) and pcDNA3.1(+)/Myc-His-CBX7 vectors for 48 hours,
proteins extracted were immunoprecipitated with mouse anti-Myc
antibody (clone 9E10, Clontech) to precipitate exogenous CBX7
protein complexes and separated by SDS-PAGE and immuno-
blotted with a GFP antibody (ProteinTech Group). The mouse
IgG antibody was used as negative control.
Supporting Information
Figure S1 DHPLC chromatogram of methylation status of p16
CpG island in human cancer cell lines.
Found at: doi:10.1371/journal.pone.0013732.s001 (0.19 MB
PDF)
Figure S2 The 3D images of chromodomain of the wildtype
CBX7 (PDB id: 2K1B) and its mutant F11A, W32A produced by
the DeepView software.
Found at: doi:10.1371/journal.pone.0013732.s002 (0.29 MB
PDF)
Figure S3 Distribution of CBX7-EGFP and CBX7-SUV39H2
complexes in human gastric carcinoma cell line MGC803.
Found at: doi:10.1371/journal.pone.0013732.s003 (0.92 MB
PDF)
Figure S4 Images of Co-IP assay for detection of CBX7-Histone
3.1 or CBX7-SUV39H2 complexes.
Found at: doi:10.1371/journal.pone.0013732.s004 (0.09 MB
PDF)
Figure S5 Effect of siRNA knockdown of HMTases G9a,
SUV39H1 and SUV39H2 on formation of H3K9me3 within the
p16 promoter and p16 expression in the CBX7 stably transfected
subclone-2.
Found at: doi:10.1371/journal.pone.0013732.s005 (0.20 MB
PDF)
Figure S6 Effect of knockdown of Suv39h2 and Suv39h1 by
siRNA on transcription of Suv39h2, Suv39h1, and p16 in PC3 cell
line stably transfected with shRNA against Cbx7 or scramble
shRNA control.
Found at: doi:10.1371/journal.pone.0013732.s006 (0.46 MB
PDF)
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